To identify whether FDX1 is an independent clinical predictor for OS in ccRCC patients, clinical characteristics, including age, gender, histological tumor grade, and pathological tumor stage, were adjusted by univariate and multivariate Cox regression analysis. The gene discussed is FDX1; the disease is nonpapillary renal cell carcinoma.